Literature DB >> 21997559

Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesis.

Sandra Baumgart1, Volker Ellenrieder, Martin E Fernandez-Zapico.   

Abstract

Transcription factors are proteins that regulate gene expression by modulating the synthesis of messenger RNA. Since this process is often one dominant control point in the production of many proteins, transcription factors represent the key regulators of numerous cellular functions, including proliferation, differentiation and apoptosis. Pancreatic cancer progression is characterised by activation of inflammatory signalling pathways converging on a limited set of transcription factors that fine-tune gene expression patterns contributing to the growth and maintenance of these tumours. Thus strategies targeting these transcriptional networks activated in pancreatic cancer cells could block the effects of upstream inflammatory responses participating in pancreatic tumorigenesis. The authors review this field of research and summarise current strategies for targeting oncogenic transcription factors and their activating signalling networks in the treatment of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21997559      PMCID: PMC3539739          DOI: 10.1136/gutjnl-2011-301008

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  65 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Downregulation of nuclear factor-kappaB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer.

Authors:  Rui Kong; Bei Sun; Hongchi Jiang; Shangha Pan; Hua Chen; Shuangjia Wang; Geoffrey W Krissansen; Xueying Sun
Journal:  Cancer Lett       Date:  2009-10-31       Impact factor: 8.679

3.  NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells.

Authors:  Alexander Köenig; Thomas Linhart; Katrin Schlengemann; Kristina Reutlinger; Jessica Wegele; Guido Adler; Garima Singh; Leonie Hofmann; Steffen Kunsch; Thomas Büch; Eva Schäfer; Thomas M Gress; Martin E Fernandez-Zapico; Volker Ellenrieder
Journal:  Gastroenterology       Date:  2009-11-06       Impact factor: 22.682

Review 4.  Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals.

Authors:  Barbara Stecca; Ariel Ruiz i Altaba
Journal:  J Mol Cell Biol       Date:  2010-01-17       Impact factor: 6.216

Review 5.  Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).

Authors:  Eléonore Beurel; Suzanne M Michalek; Richard S Jope
Journal:  Trends Immunol       Date:  2009-10-14       Impact factor: 16.687

6.  The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer.

Authors:  Volker Fendrich; Nai-Ming Chen; Meike Neef; Jens Waldmann; Malte Buchholz; Georg Feldmann; Emily P Slater; Anirban Maitra; Detlef K Bartsch
Journal:  Gut       Date:  2009-11-01       Impact factor: 23.059

Review 7.  IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis.

Authors:  Julia Bollrath; Florian R Greten
Journal:  EMBO Rep       Date:  2009-11-06       Impact factor: 8.807

Review 8.  NFAT proteins: emerging roles in cancer progression.

Authors:  Maria Mancini; Alex Toker
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

Review 9.  NF-kappaB as a critical link between inflammation and cancer.

Authors:  Michael Karin
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-11       Impact factor: 10.005

Review 10.  Inflammation and oncogenesis: a vicious connection.

Authors:  Sergei I Grivennikov; Michael Karin
Journal:  Curr Opin Genet Dev       Date:  2009-12-25       Impact factor: 5.578

View more
  27 in total

1.  NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.

Authors:  Nai-Ming Chen; Garima Singh; Alexander Koenig; Geou-Yarh Liou; Peter Storz; Jin-San Zhang; Lisanne Regul; Sankari Nagarajan; Benjamin Kühnemuth; Steven A Johnsen; Matthias Hebrok; Jens Siveke; Daniel D Billadeau; Volker Ellenrieder; Elisabeth Hessmann
Journal:  Gastroenterology       Date:  2015-01-23       Impact factor: 22.682

Review 2.  Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer.

Authors:  Ilya Gukovsky; Ning Li; Jelena Todoric; Anna Gukovskaya; Michael Karin
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

Review 3.  Heparanase: From basic research to therapeutic applications in cancer and inflammation.

Authors:  Israel Vlodavsky; Preeti Singh; Ilanit Boyango; Lilach Gutter-Kapon; Michael Elkin; Ralph D Sanderson; Neta Ilan
Journal:  Drug Resist Updat       Date:  2016-10-06       Impact factor: 18.500

4.  Macrophage polarization in pancreatic carcinoma: role of heparanase enzyme.

Authors:  Esther Hermano; Amichay Meirovitz; Karen Meir; Gabriel Nussbaum; Limor Appelbaum; Tamar Peretz; Michael Elkin
Journal:  J Natl Cancer Inst       Date:  2014-10-18       Impact factor: 13.506

5.  Inflammation-Induced Abnormal Expression of Self-molecules on Epithelial Cells: Targets for Tumor Immunoprevention.

Authors:  Camille Jacqueline; Amanda Lee; Nolan Frey; Jonathan S Minden; Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2020-05-28       Impact factor: 11.151

Review 6.  Targeting inflammation in pancreatic cancer: Clinical translation.

Authors:  Colin William Steele; Nina Angharad Kaur Gill; Nigel Balfour Jamieson; Christopher Ross Carter
Journal:  World J Gastrointest Oncol       Date:  2016-04-15

7.  Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D.

Authors:  Sandra Baumgart; Nai-Ming Chen; Jens T Siveke; Alexander König; Jin-San Zhang; Shiv K Singh; Elmar Wolf; Marek Bartkuhn; Irene Esposito; Elisabeth Heßmann; Johanna Reinecke; Julius Nikorowitsch; Marius Brunner; Garima Singh; Martin E Fernandez-Zapico; Thomas Smyrk; William R Bamlet; Martin Eilers; Albrecht Neesse; Thomas M Gress; Daniel D Billadeau; David Tuveson; Raul Urrutia; Volker Ellenrieder
Journal:  Cancer Discov       Date:  2014-04-02       Impact factor: 39.397

Review 8.  Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents.

Authors:  Mami Takahashi; Michihiro Mutoh; Rikako Ishigamori; Gen Fujii; Toshio Imai
Journal:  Semin Immunopathol       Date:  2012-09-07       Impact factor: 9.623

Review 9.  Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.

Authors:  Umashankar K Ballehaninna; Ronald S Chamberlain
Journal:  Tumour Biol       Date:  2013-08-17

10.  Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer.

Authors:  Michele T Yip-Schneider; Huangbing Wu; Keith Stantz; Narasimhan Agaram; Peter A Crooks; C Max Schmidt
Journal:  BMC Cancer       Date:  2013-04-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.